Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (2)

2023

  1. RSPO4 is a potential risk gene of stages III–IV, grade C periodontitis through effects on innate immune response and oral barrier integrity

    Journal of Clinical Periodontology, Vol. 50, Núm. 4, pp. 476-486

  2. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161